RANDIE LUGENBEAL: Open Payments
NPI 1376207019 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 22 payments from 10 companies in 2025. Trend: 2023 $128 · 2024 $430 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 5 | $73 |
| Sage Therapeutics, LLC | 3 | $73 |
| Astellas Pharma US Inc | 3 | $71 |
| Davol Inc. | 3 | $65 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Exeltis, USA Inc. | 2 | $37 |
| Novo Nordisk Inc | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: ZURZUVAE, Veozah, ARISTA, NEXPLANON, GEMTESA, SLYND, Sogroya, Qelbree.
Industry payments across PA — which companies pay providers there.
